Table 1 Differences in patient characteristics stratified by ILD subtypes
From: Cost drivers in the pharmacological treatment of interstitial lung disease
IPF N = 72 | PF-ILD (N = 32) | Sarcoidosis N = 45 | Other ILD N = 122 | p-value | |
|---|---|---|---|---|---|
Mean FVC % at t0 | 72.9 (21.3) | 83.7 (21.3) | 74.6 (16.9) | 67.8 (20.2) | 0.0016* |
Mean DLCO % at t0 | 38.9 (12.0) | 57.3 (19.2) | 55.7 (18.0) | 39.0 (13.1) | 0.0010* |
Mean age, years (SD) | 71.3 (6.5) | 57.9 (13.3) | 52.0 (12.1) | 62.2 (12.4) | < 0.0001* |
disease duration, years (SD) | 2.4 (1.9) | 5.4 (6.3) | 8.1 (10.1) | 3.1 (4.6) | < 0.0001* |
Mean number of comorbidities (SD) | 3.8 (1.7) | 2.5 (1.3) | 2.4 (1.3) | 2.8 (1.5) | < 0.0001* |
Male (%) | 57 (79.2) | 23 (71.2) | 33 (73.3) | 66 (54.1) | 0.0020* |
Never smoker (%) | 19 (26.4) | 16 (50.0) | 19 (42.2) | 46 (37.7) | 0.0955 |